Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 8.24M | 17.22M | 5.29M | 5.14M | 14.20M | 22.30M |
Gross Profit | 2.15M | 7.14M | 648.00K | 1.60M | 1.91M | 11.23M |
EBITDA | -15.09M | -10.81M | -13.70M | -23.32M | -40.95M | 1.50M |
Net Income | -16.52M | -15.48M | -18.33M | -27.56M | -41.57M | -7.00K |
Balance Sheet | ||||||
Total Assets | 73.26M | 79.93M | 82.82M | 71.30M | 101.22M | 23.48M |
Cash, Cash Equivalents and Short-Term Investments | 48.47M | 55.29M | 58.63M | 44.52M | 71.12M | 2.04M |
Total Debt | 15.82M | 18.28M | 20.68M | 23.23M | 22.71M | 11.90M |
Total Liabilities | 54.62M | 68.77M | 57.23M | 28.49M | 31.34M | 18.86M |
Stockholders Equity | 18.62M | 11.14M | 25.57M | 42.80M | 69.88M | 4.61M |
Cash Flow | ||||||
Free Cash Flow | 12.99M | -567.00K | 17.11M | -23.98M | -36.43M | 1.27M |
Operating Cash Flow | 13.05M | -308.00K | 17.25M | -23.84M | -32.78M | 1.53M |
Investing Cash Flow | -3.91M | 6.96M | -7.47M | 42.34M | -45.22M | 812.00K |
Financing Cash Flow | -3.01M | -2.83M | -2.38M | -3.17M | 105.08M | -1.19M |
Razor Labs Ltd. has announced the exercise of options on behalf of the company. This announcement emphasizes various regulations involved in the process and indicates a significant operational move for Razor Labs, potentially impacting their positioning and stakeholder interests.